Springer Ingo N G, Niehoff Peter, Açil Yahya, Marget Matthias, Lange Arne, Warnke Patrick H, Pielenz Helge, Roldán J Camilo, Wiltfang Jörg
Department of Oral and Maxillofacial Surgery, University of Kiel, Germany.
J Craniomaxillofac Surg. 2008 Jun;36(4):210-7. doi: 10.1016/j.jcms.2007.09.001. Epub 2007 Oct 22.
Basic fibroblast growth factor (bFGF) is considered to enhance angiogenesis and to support bone formation in the presence of vital bone cells. Bone morphogenetic protein-2 (rhBMP-2) is known to induce bone formation. The aim of this study was to analyze the effect of bFGF and rhBMP-2 in the irradiated mandible.
The right mandibles of 24 rats were irradiated with a single dose of 20 Gy at a high-dose-rate (HDR) after loading machine (bio effective equivalent dose to ca. 45 x 2 Gy). After 12 weeks 100 microg rhBMP-2 (n=6 animals, group 1), 100 microg bFGF (n=6 animals, group 2) and 100 microg rhBMP-2 plus 100 microg bFGF (n=6 animals, group 3) were injected along the right mandible (left mandible: no irradiation, no growth factor). Another 6 animals (group 4) remained untreated after the irradiation. After another 7 weeks the specimens were examined by non-decalcified histology.
Bone apposition of the experimental versus control sides was not statistically significantly different when one of the growth factors was applied alone (rhBMP-2: p=0.917; bFGF: p=0.345). Average bone apposition was significantly decreased on the experimental sides of group 3 (rhBMP-2+bFGF: p=0.046) and group 4 (p=0.008). Average bone densities were unaffected in all settings (for all p>0.1).
The application of bFGF and the application of rhBMP-2 alone did result in predictable bone generation in the irradiated mandible with the bone apposition being equal to that of the non-irradiated side. The application of both growth factors together or none at all after irradiation results in significantly reduced bone apposition.
碱性成纤维细胞生长因子(bFGF)被认为在有活力的骨细胞存在的情况下可促进血管生成并支持骨形成。骨形态发生蛋白-2(rhBMP-2)已知可诱导骨形成。本研究的目的是分析bFGF和rhBMP-2在受照射下颌骨中的作用。
24只大鼠的右侧下颌骨在加载机器后以高剂量率(HDR)单次照射20 Gy(生物等效剂量约为45×2 Gy)。12周后,将100μg rhBMP-2(n = 6只动物,第1组)、100μg bFGF(n = 6只动物,第2组)和100μg rhBMP-2加100μg bFGF(n = 6只动物,第3组)沿右侧下颌骨注射(左侧下颌骨:未照射,未使用生长因子)。另外6只动物(第4组)在照射后未接受治疗。再过7周后,通过非脱钙组织学检查标本。
单独应用一种生长因子时,实验组与对照侧的骨附着在统计学上无显著差异(rhBMP-2:p = 0.917;bFGF:p = 0.345)。第3组(rhBMP-2 + bFGF:p = 0.046)和第4组(p = 0.008)的实验组平均骨附着显著降低。所有情况下平均骨密度均未受影响(所有p>0.1)。
单独应用bFGF和rhBMP-2确实能在受照射的下颌骨中产生可预测的骨生成,其骨附着与未照射侧相当。照射后同时应用两种生长因子或不应用任何生长因子均会导致骨附着显著减少。